Healthcare Sector Stocks
The Healthcare sector has a total of 1049 stocks, with a combined market cap of $9.13 trillion, total revenue of $4.67 trillion and a weighted average PE ratio of 47.20.
Market Cap
9.13T
Revenue
4.67T
Profits
193.51B
PE Ratio
47.20
Profit Margin
4.15%
Dividend Yield
0.40%
1048 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 1.03T | -1.94% | 986,272 | 79.67B |
| 2 | JNJ | Johnson & Johnson | 599.58B | -5.66% | 10,431,762 | 97.93B |
| 3 | ABBV | AbbVie Inc. | 484.30B | -2.51% | 2,933,003 | 64.39B |
| 4 | MRK | Merck & Co., Inc. | 349.94B | -2.48% | 4,118,072 | 66.57B |
| 5 | UNH | UnitedHealth Group Incorporated | 338.71B | -0.31% | 9,840,487 | 450.06B |
| 6 | NVS | Novartis AG | 271.00B | -0.81% | 1,459,802 | 56.69B |
| 7 | TMO | Thermo Fisher Scientific Inc. | 245.51B | 0.26% | 1,129,978 | 46.34B |
| 8 | AZN | AstraZeneca PLC | 241.34B | -1.26% | 1,829,354 | 61.37B |
| 9 | AMGN | Amgen Inc. | 223.38B | -1.05% | 927,160 | 38.10B |
| 10 | GILD | Gilead Sciences, Inc. | 183.74B | -1.50% | 4,114,779 | 30.46B |
| 11 | ABT | Abbott Laboratories | 178.61B | 1.37% | 5,073,763 | 46.59B |
| 12 | NVO | Novo Nordisk A/S | 167.05B | -1.40% | 6,216,150 | 50.34B |
| 13 | PFE | Pfizer Inc. | 161.76B | -0.07% | 14,582,037 | 63.70B |
| 14 | DHR | Danaher Corporation | 158.59B | 1.99% | 3,336,541 | 25.11B |
| 15 | ISRG | Intuitive Surgical, Inc. | 149.38B | -1.12% | 993,284 | 11.03B |
| 16 | VRTX | Vertex Pharmaceuticals Incorporated | 123.98B | -3.52% | 577,553 | 12.59B |
| 17 | MDT | Medtronic plc | 118.34B | 0.63% | 8,587,575 | 37.54B |
| 18 | BMY | Bristol-Myers Squibb Company | 115.85B | -1.50% | 9,235,425 | 49.19B |
| 19 | MCK | McKesson Corporation | 112.60B | 1.04% | 397,578 | 410.98B |
| 20 | CVS | CVS Health Corporation | 112.18B | -0.03% | 3,352,653 | 412.65B |
| 21 | SYK | Stryker Corporation | 108.72B | 0.30% | 1,244,572 | 25.84B |
| 22 | HCA | HCA Healthcare, Inc. | 99.93B | 0.65% | 695,231 | 78.01B |
| 23 | SNY | Sanofi | 93.60B | -1.35% | 2,813,148 | 55.89B |
| 24 | ELV | Elevance Health, Inc. | 92.20B | 0.72% | 771,728 | 201.11B |
| 25 | GSK | GSK plc | 91.94B | -1.19% | 3,894,398 | 44.05B |
| 26 | MRNA | Moderna, Inc. | 86.63B | 1.53% | 10,339,023 | 2.23B |
| 27 | REGN | Regeneron Pharmaceuticals, Inc. | 75.29B | -1.16% | 362,488 | 15.53B |
| 28 | CI | The Cigna Group | 74.80B | -0.09% | 649,966 | 282.38B |
| 29 | BSX | Boston Scientific Corporation | 63.14B | -0.62% | 9,307,260 | 21.00B |
| 30 | COR | Cencora, Inc. | 62.99B | 1.55% | 577,787 | 332.77B |
| 31 | TAK | Takeda Pharmaceutical Company Limited | 59.78B | -0.54% | 1,952,076 | 28.42B |
| 32 | NTRA | Natera, Inc. | 56.86B | -0.83% | 836,751 | 2.71B |
| 33 | CAH | Cardinal Health, Inc. | 55.37B | 0.43% | 810,490 | 254.25B |
| 34 | BDX | Becton, Dickinson and Company | 51.23B | -0.44% | 552,769 | 22.48B |
| 35 | HUM | Humana Inc. | 51.16B | -1.71% | 1,396,528 | 145.68B |
| 36 | ARGX | argenx SE | 50.53B | -1.35% | 198,418 | 5.32B |
| 37 | EW | Edwards Lifesciences Corporation | 49.52B | -0.56% | 1,460,049 | 6.51B |
| 38 | VEEV | Veeva Systems Inc. | 49.21B | 2.73% | 1,727,404 | 3.46B |
| 39 | A | Agilent Technologies, Inc. | 48.62B | 0.65% | 776,023 | 7.37B |
| 40 | TEVA | Teva Pharmaceutical Industries Limited | 47.81B | -0.34% | 4,381,142 | 17.32B |
| 41 | MDLN | Medline Inc. | 46.82B | -0.42% | 2,091,573 | 29.94B |
| 42 | IQV | IQVIA Holdings Inc. | 43.08B | -0.19% | 811,696 | 16.98B |
| 43 | WAT | Waters Corporation | 42.12B | -0.78% | 701,859 | 4.64B |
| 44 | HLN | Haleon plc | 41.26B | -0.42% | 11,266,112 | 14.80B |
| 45 | IDXX | IDEXX Laboratories, Inc. | 40.89B | -0.94% | 210,908 | 4.55B |
| 46 | ILMN | Illumina, Inc. | 40.83B | -2.26% | 1,276,908 | 4.49B |
| 47 | RVMD | Revolution Medicines, Inc. | 40.46B | -2.68% | 1,779,782 | - |
| 48 | ONC | BeOne Medicines AG | 39.83B | -0.03% | 162,051 | 6.13B |
| 49 | CNC | Centene Corporation | 34.17B | 3.20% | 3,463,606 | 180.30B |
| 50 | BIIB | Biogen Inc. | 33.75B | -0.44% | 594,721 | 10.03B |
| 51 | RMD | ResMed Inc. | 33.00B | 0.02% | 380,456 | 5.65B |
| 52 | RPRX | Royalty Pharma plc | 32.54B | -2.06% | 1,776,088 | 2.54B |
| 53 | DXCM | DexCom, Inc. | 32.36B | -0.20% | 1,296,164 | 4.97B |
| 54 | MTD | Mettler-Toledo International Inc. | 32.13B | 2.61% | 125,656 | 4.13B |
| 55 | GEHC | GE HealthCare Technologies Inc. | 31.20B | 1.98% | 1,843,107 | 21.27B |
| 56 | ZTS | Zoetis Inc. | 30.87B | -1.26% | 1,419,435 | 9.53B |
| 57 | ALNY | Alnylam Pharmaceuticals, Inc. | 29.89B | -1.60% | 654,422 | 4.80B |
| 58 | ALC | Alcon Inc. | 29.88B | -1.83% | 1,951,571 | 10.86B |
| 59 | WST | West Pharmaceutical Services, Inc. | 26.21B | 1.33% | 241,530 | 3.33B |
| 60 | LH | Labcorp Holdings Inc. | 25.60B | 0.03% | 167,961 | 14.35B |
| 61 | DGX | Quest Diagnostics Incorporated | 25.59B | -0.35% | 477,191 | 11.56B |
| 62 | PHG | Koninklijke Philips N.V. | 24.47B | 0.67% | 766,518 | 20.18B |
| 63 | ROIV | Roivant Sciences Ltd. | 24.10B | -3.53% | 2,168,213 | 7.53M |
| 64 | UTHR | United Therapeutics Corporation | 23.48B | -0.50% | 216,635 | 3.15B |
| 65 | BNTX | BioNTech SE | 22.55B | -6.33% | 1,365,581 | 3.03B |
| 66 | INCY | Incyte Corporation | 21.96B | -2.69% | 1,522,387 | 5.82B |
| 67 | GH | Guardant Health, Inc. | 21.87B | 0.12% | 789,383 | 1.18B |
| 68 | THC | Tenet Healthcare Corporation | 21.63B | -0.04% | 367,501 | 21.81B |
| 69 | GMAB | Genmab A/S | 21.47B | -2.41% | 2,836,778 | 4.13B |
| 70 | STE | STERIS plc | 21.21B | -0.68% | 265,666 | 6.04B |
| 71 | INSM | Insmed Incorporated | 21.19B | -1.56% | 1,331,570 | 1.14B |
| 72 | VTRS | Viatris Inc. | 19.94B | -1.03% | 3,400,711 | 14.74B |
| 73 | ZBH | Zimmer Biomet Holdings, Inc. | 17.72B | 0.78% | 1,258,921 | 8.51B |
| 74 | RVTY | Revvity, Inc. | 17.37B | 0.04% | 789,575 | 2.91B |
| 75 | MEDP | Medpace Holdings, Inc. | 17.13B | -1.00% | 88,277 | 2.78B |
| 76 | SOLV | Solventum Corporation | 14.69B | 1.17% | 436,921 | 8.31B |
| 77 | ASND | Ascendis Pharma A/S | 14.69B | -1.45% | 383,777 | 1.20B |
| 78 | EXEL | Exelixis, Inc. | 14.68B | -0.94% | 1,360,988 | 2.44B |
| 79 | CRL | Charles River Laboratories International, Inc. | 14.40B | -0.09% | 428,943 | 4.00B |
| 80 | NBIX | Neurocrine Biosciences, Inc. | 13.78B | -4.08% | 809,279 | 3.37B |
| 81 | JAZZ | Jazz Pharmaceuticals plc | 13.68B | -2.76% | 503,005 | 4.60B |
| 82 | BAX | Baxter International Inc. | 12.92B | 0.85% | 1,614,714 | 11.47B |
| 83 | BTSG | BrightSpring Health Services, Inc. | 12.91B | -1.62% | 818,027 | 14.37B |
| 84 | CORT | Corcept Therapeutics Incorporated | 12.75B | -2.71% | 303,659 | 830.81M |
| 85 | ICLR | ICON Public Limited Company | 12.72B | 0.26% | 520,767 | 8.29B |
| 86 | PEN | Penumbra, Inc. | 12.59B | -0.42% | 96,882 | 1.50B |
| 87 | SMMT | Summit Therapeutics Inc. | 12.56B | -8.29% | 4,820,463 | - |
| 88 | HALO | Halozyme Therapeutics, Inc. | 12.43B | -1.37% | 1,081,386 | 1.66B |
| 89 | TEM | Tempus AI, Inc. | 12.36B | 0.74% | 2,850,771 | 1.43B |
| 90 | BBIO | BridgeBio Pharma, Inc. | 12.36B | -3.86% | 1,591,103 | 713.07M |
| 91 | EHC | Encompass Health Corporation | 12.30B | 0.21% | 338,056 | 6.21B |
| 92 | SNN | Smith & Nephew plc | 11.81B | 1.01% | 691,233 | 6.30B |
| 93 | DVA | DaVita Inc. | 11.60B | 0.03% | 178,661 | 14.01B |
| 94 | TECH | Bio-Techne Corporation | 11.37B | -0.07% | 1,787,754 | 1.22B |
| 95 | FMS | Fresenius Medical Care AG | 11.19B | -0.47% | 784,829 | 22.19B |
| 96 | ELAN | Elanco Animal Health Incorporated | 11.13B | -1.29% | 1,448,633 | 5.02B |
| 97 | MOH | Molina Healthcare, Inc. | 11.09B | 4.19% | 630,644 | 42.47B |
| 98 | RDY | Dr. Reddy's Laboratories Limited | 10.79B | -0.16% | 1,583,593 | 3.50B |
| 99 | PCVX | Vaxcyte, Inc. | 10.63B | -4.44% | 1,325,572 | - |
| 100 | AVTR | Avantor, Inc. | 10.58B | 0.97% | 1,929,273 | 6.56B |
| 101 | UHS | Universal Health Services, Inc. | 10.56B | 0.21% | 251,806 | 18.11B |
| 102 | BMRN | BioMarin Pharmaceutical Inc. | 10.50B | -2.08% | 1,380,607 | 3.41B |
| 103 | IBRX | ImmunityBio, Inc. | 10.46B | -2.52% | 8,600,239 | 165.79M |
| 104 | COO | The Cooper Companies, Inc. | 10.45B | -1.09% | 1,250,778 | 4.24B |
| 105 | OSCR | Oscar Health, Inc. | 10.41B | -0.74% | 3,292,676 | 15.32B |
| 106 | MDGL | Madrigal Pharmaceuticals, Inc. | 10.40B | -3.62% | 169,483 | 1.28B |
| 107 | GMED | Globus Medical, Inc. | 10.25B | 0.16% | 470,209 | 3.14B |
| 108 | ALGN | Align Technology, Inc. | 10.18B | 2.06% | 620,614 | 4.14B |
| 109 | ENSG | The Ensign Group, Inc. | 10.02B | -0.28% | 130,922 | 5.49B |
| 110 | RGEN | Repligen Corporation | 10.00B | 2.68% | 720,105 | 785.10M |
| 111 | GKOS | Glaukos Corporation | 9.88B | -0.26% | 444,926 | 612.84M |
| 112 | BIO | Bio-Rad Laboratories, Inc. | 9.75B | 0.11% | 51,320 | 2.59B |
| 113 | PODD | Insulet Corporation | 9.66B | -0.35% | 497,762 | 3.05B |
| 114 | KRYS | Krystal Biotech, Inc. | 9.60B | -2.35% | 133,240 | 440.48M |
| 115 | TWST | Twist Bioscience Corporation | 9.47B | -0.51% | 1,062,809 | 431.80M |
| 116 | HSIC | Henry Schein, Inc. | 9.45B | 0.67% | 331,920 | 13.60B |
| 117 | QGEN | Qiagen N.V. | 9.43B | 0.67% | 912,576 | 2.10B |
| 118 | TXG | 10x Genomics, Inc. | 9.39B | -4.19% | 2,643,837 | 616.91M |
| 119 | PTGX | Protagonist Therapeutics, Inc. | 8.98B | -4.19% | 550,564 | 281.99M |
| 120 | KYMR | Kymera Therapeutics, Inc. | 8.94B | -4.05% | 372,296 | 105.00M |
| 121 | CYTK | Cytokinetics, Incorporated | 8.65B | -0.92% | 1,048,914 | 67.67M |
| 122 | BRKR | Bruker Corporation | 8.62B | 0.62% | 1,275,210 | 3.50B |
| 123 | HNGE | Hinge Health, Inc. | 8.45B | -0.07% | 454,080 | 720.06M |
| 124 | CAI | Caris Life Sciences, Inc. | 8.36B | -0.35% | 2,251,667 | 989.61M |
| 125 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.29B | -3.33% | 1,353,647 | 669.50M |
| 126 | AXSM | Axsome Therapeutics, Inc. | 8.17B | -6.05% | 789,357 | 776.57M |
| 127 | SYRE | Spyre Therapeutics, Inc. | 7.69B | -4.24% | 861,333 | - |
| 128 | TGTX | TG Therapeutics, Inc. | 7.68B | -2.09% | 527,134 | 799.54M |
| 129 | ATR | AptarGroup, Inc. | 7.62B | 0.69% | 356,696 | 3.93B |
| 130 | HQY | HealthEquity, Inc. | 7.49B | -1.55% | 442,867 | 1.36B |
| 131 | ABVX | ABIVAX Société Anonyme | 7.47B | -1.91% | 722,018 | 5.33M |
| 132 | IONS | Ionis Pharmaceuticals, Inc. | 7.09B | -2.32% | 1,260,184 | 874.09M |
| 133 | PACS | PACS Group, Inc. | 7.04B | 0.36% | 271,573 | 5.55B |
| 134 | HIMS | Hims & Hers Health, Inc. | 6.87B | -3.92% | 6,712,659 | 2.58B |
| 135 | PRAX | Praxis Precision Medicines, Inc. | 6.81B | -3.00% | 234,285 | 7.46M |
| 136 | AMRX | Amneal Pharmaceuticals, Inc. | 6.79B | -2.72% | 975,035 | 3.12B |
| 137 | ALKS | Alkermes plc | 6.69B | -0.94% | 478,889 | 1.67B |
| 138 | IOVA | Iovance Biotherapeutics, Inc. | 6.61B | 0.17% | 7,054,394 | 324.97M |
| 139 | CHE | Chemed Corporation | 6.54B | 0.43% | 60,015 | 2.60B |
| 140 | LNTH | Lantheus Holdings, Inc. | 6.53B | -0.06% | 1,158,973 | 1.56B |
| 141 | GRFS | Grifols, S.A. | 6.50B | -2.65% | 316,840 | 8.48B |
| 142 | GRAL | GRAIL, Inc. | 6.25B | 1.85% | 416,763 | 165.26M |
| 143 | KNSA | Kiniksa Pharmaceuticals International, plc | 6.17B | -0.25% | 333,551 | 840.85M |
| 144 | BLTE | Belite Bio, Inc | 6.12B | -4.25% | 144,026 | - |
| 145 | LGND | Ligand Pharmaceuticals Incorporated | 6.01B | -3.11% | 108,427 | 290.54M |
| 146 | RYTM | Rhythm Pharmaceuticals, Inc. | 6.00B | -2.90% | 328,286 | 239.92M |
| 147 | IMVT | Immunovant, Inc. | 5.97B | -2.00% | 661,551 | - |
| 148 | KOD | Kodiak Sciences Inc. | 5.77B | -7.39% | 997,345 | - |
| 149 | BLCO | Bausch + Lomb Corporation | 5.66B | -1.37% | 462,692 | 5.32B |
| 150 | RDNT | RadNet, Inc. | 5.64B | 0.17% | 229,133 | 2.27B |
| 151 | CGON | CG Oncology, Inc. | 5.58B | -0.32% | 489,690 | 6.23M |
| 152 | HAE | Haemonetics Corporation | 5.58B | 0.40% | 445,720 | 1.35B |
| 153 | DOCS | Doximity, Inc. | 5.52B | 1.31% | 1,336,171 | 655.57M |
| 154 | MMED | MiniMed Group, Inc. | 5.28B | -0.13% | 10,148,739 | 3.22B |
| 155 | TFX | Teleflex Incorporated | 5.28B | -0.85% | 320,807 | 2.25B |
| 156 | MMSI | Merit Medical Systems, Inc. | 5.26B | -1.79% | 498,377 | 1.58B |
| 157 | MIRM | Mirum Pharmaceuticals, Inc. | 5.25B | -6.00% | 422,886 | 618.07M |
| 158 | ORKA | Oruka Therapeutics, Inc. | 5.22B | -1.79% | 255,835 | - |
| 159 | STVN | Stevanato Group S.p.A. | 5.19B | -1.14% | 239,153 | 1.40B |
| 160 | SHC | Sotera Health Company | 5.19B | 0.28% | 725,191 | 1.22B |
| 161 | ERAS | Erasca, Inc. | 5.16B | -4.59% | 2,795,975 | - |
| 162 | PTCT | PTC Therapeutics, Inc. | 5.01B | -4.58% | 410,347 | 1.01B |
| 163 | SRRK | Scholar Rock Holding Corporation | 5.01B | -2.00% | 419,344 | - |
| 164 | WAY | Waystar Holding Corp. | 5.00B | -2.10% | 827,904 | 1.21B |
| 165 | COGT | Cogent Biosciences, Inc. | 4.93B | -4.70% | 1,294,838 | - |
| 166 | MANE | Veradermics, Incorporated | 4.92B | -3.79% | 256,505 | - |
| 167 | TVTX | Travere Therapeutics, Inc. | 4.89B | -0.36% | 882,317 | 591.33M |
| 168 | CRSP | CRISPR Therapeutics AG | 4.86B | -2.56% | 870,537 | 13.39M |
| 169 | CON | Concentra Group Holdings Parent, Inc. | 4.81B | 0.45% | 594,446 | 2.29B |
| 170 | LFST | LifeStance Health Group, Inc. | 4.71B | -1.16% | 1,147,558 | 1.58B |
| 171 | OPCH | Option Care Health, Inc. | 4.66B | 0.08% | 2,171,021 | 5.69B |
| 172 | DFTX | Definium Therapeutics, Inc. | 4.60B | -2.78% | 1,091,419 | - |
| 173 | BLLN | BillionToOne, Inc. | 4.43B | 0.88% | 483,735 | 397.41M |
| 174 | HTFL | HeartFlow, Inc. | 4.39B | -0.08% | 778,831 | 212.07M |
| 175 | DNTH | Dianthus Therapeutics, Inc. | 4.35B | -4.70% | 552,764 | 1.90M |
| 176 | ITGR | Integer Holdings Corporation | 4.31B | 0.10% | 424,015 | 1.84B |
| 177 | LIVN | LivaNova PLC | 4.24B | -0.28% | 237,858 | 1.47B |
| 178 | RGC | Regencell Bioscience Holdings Limited | 4.23B | 19.78% | 463,843 | - |
| 179 | INDV | Indivior Pharmaceuticals, Inc. | 4.17B | -1.90% | 859,016 | 1.33B |
| 180 | ICUI | ICU Medical, Inc. | 4.09B | -0.26% | 119,476 | 2.16B |
| 181 | ABCL | AbCellera Biologics Inc. | 4.07B | -0.67% | 2,126,597 | 66.17M |
| 182 | ADPT | Adaptive Biotechnologies Corporation | 4.06B | -0.47% | 1,143,895 | 308.08M |
| 183 | EWTX | Edgewise Therapeutics, Inc. | 3.96B | -5.23% | 349,674 | - |
| 184 | TNGX | Tango Therapeutics, Inc. | 3.85B | -5.63% | 3,319,223 | 53.81M |
| 185 | RLAY | Relay Therapeutics, Inc. | 3.81B | -3.34% | 852,435 | 10.35M |
| 186 | NVST | Envista Holdings Corporation | 3.63B | -0.55% | 1,324,455 | 2.86B |
| 187 | NHC | National HealthCare Corporation | 3.63B | 0.77% | 33,667 | 1.56B |
| 188 | OGN | Organon & Co. | 3.62B | 0.07% | 1,844,236 | 6.13B |
| 189 | TLX | Telix Pharmaceuticals Limited | 3.61B | -3.41% | 281,174 | 890.79M |
| 190 | PLSE | Pulse Biosciences, Inc. | 3.51B | -6.22% | 239,146 | 1.19M |
| 191 | IRTC | iRhythm Holdings, Inc. | 3.50B | -0.37% | 284,321 | 825.34M |
| 192 | VCYT | Veracyte, Inc. | 3.48B | -1.59% | 333,583 | 561.90M |
| 193 | LEGN | Legend Biotech Corporation | 3.46B | 0.22% | 1,524,845 | 1.27B |
| 194 | CDNA | CareDx, Inc. | 3.45B | 5.61% | 997,594 | 458.09M |
| 195 | AMLX | Amylyx Pharmaceuticals, Inc. | 3.41B | -1.02% | 588,018 | -665.00K |
| 196 | PBLS | Parabilis Medicines, Inc. | 3.36B | -5.94% | 780,270 | 148.00K |
| 197 | XENE | Xenon Pharmaceuticals Inc. | 3.34B | -3.66% | 583,119 | 7.50M |
| 198 | IDYA | IDEAYA Biosciences, Inc. | 3.32B | -4.49% | 529,717 | 234.13M |
| 199 | ARQT | Arcutis Biotherapeutics, Inc. | 3.30B | - | 944,663 | 463.98M |
| 200 | WRBY | Warby Parker Inc. | 3.24B | 0.88% | 1,622,338 | 911.61M |
| 201 | ACAD | Acadia Pharmaceuticals Inc. | 3.21B | -4.07% | 1,223,192 | 1.14B |
| 202 | VKTX | Viking Therapeutics, Inc. | 3.16B | -4.52% | 4,154,649 | - |
| 203 | TARS | Tarsus Pharmaceuticals, Inc. | 3.14B | -3.97% | 477,619 | 606.33M |
| 204 | CELC | Celcuity Inc. | 3.11B | -3.39% | 651,512 | - |
| 205 | DNLI | Denali Therapeutics Inc. | 2.93B | -3.11% | 1,011,493 | 3.60M |
| 206 | ATRC | AtriCure, Inc. | 2.91B | -0.14% | 332,607 | 569.62M |
| 207 | RCUS | Arcus Biosciences, Inc. | 2.90B | -6.41% | 729,577 | 117.00M |
| 208 | ELVN | Enliven Therapeutics, Inc. | 2.90B | -3.09% | 404,704 | - |
| 209 | DYN | Dyne Therapeutics, Inc. | 2.89B | -3.01% | 1,853,459 | - |
| 210 | ACHC | Acadia Healthcare Company, Inc. | 2.84B | 1.40% | 675,717 | 3.37B |
| 211 | PRVA | Privia Health Group, Inc. | 2.76B | 0.89% | 1,154,777 | 2.36B |
| 212 | TMDX | TransMedics Group, Inc. | 2.74B | 1.08% | 682,432 | 668.47M |
| 213 | PGEN | Precigen, Inc. | 2.70B | -1.44% | 1,340,158 | 85.72M |
| 214 | AVAH | Aveanna Healthcare Holdings Inc. | 2.66B | -0.25% | 955,281 | 2.60B |
| 215 | NEOG | Neogen Corporation | 2.59B | -1.08% | 1,144,802 | 884.00M |
| 216 | ZLAB | Zai Lab Limited | 2.59B | -6.34% | 490,531 | 449.61M |
| 217 | CLOV | Clover Health Investments, Corp. | 2.55B | 0.52% | 2,560,464 | 2.48B |
| 218 | GRDN | Guardian Pharmacy Services, Inc. | 2.53B | -1.48% | 131,190 | 1.46B |
| 219 | SLS | SELLAS Life Sciences Group, Inc. | 2.51B | 4.27% | 5,105,593 | - |
| 220 | BEAM | Beam Therapeutics Inc. | 2.44B | -2.67% | 971,795 | 156.04M |
| 221 | SUPN | Supernus Pharmaceuticals, Inc. | 2.44B | -2.01% | 934,535 | 830.44M |
| 222 | HCM | HUTCHMED (China) Limited | 2.44B | -1.35% | 26,945 | 549.12M |
| 223 | BKD | Brookdale Senior Living Inc. | 2.41B | -1.32% | 4,090,105 | 2.93B |
| 224 | NAMS | NewAmsterdam Pharma Company N.V. | 2.41B | -5.08% | 498,967 | 7.12M |
| 225 | LQDA | Liquidia Corporation | 2.39B | -3.40% | 1,950,241 | 450.91M |
| 226 | MBX | MBX Biosciences, Inc. | 2.38B | -4.94% | 466,933 | - |
| 227 | NRIX | Nurix Therapeutics, Inc. | 2.33B | 1.26% | 2,125,416 | 701.94M |
| 228 | PBH | Prestige Consumer Healthcare Inc. | 2.32B | -0.18% | 273,854 | 1.10B |
| 229 | ADMA | ADMA Biologics, Inc. | 2.29B | 0.64% | 1,770,143 | 512.28M |
| 230 | UFPT | UFP Technologies, Inc. | 2.27B | -0.78% | 69,971 | 631.64M |
| 231 | CLDX | Celldex Therapeutics, Inc. | 2.22B | -3.98% | 1,057,976 | 158.00K |
| 232 | BHC | Bausch Health Companies Inc. | 2.20B | -1.01% | 1,079,725 | 10.85B |
| 233 | AUPH | Aurinia Pharmaceuticals Inc. | 2.18B | -0.85% | 593,900 | 311.51M |
| 234 | IRON | Disc Medicine, Inc. | 2.18B | -6.03% | 362,857 | - |
| 235 | BFLY | Butterfly Network, Inc. | 2.18B | -4.33% | 3,314,300 | 112.14M |
| 236 | HRMY | Harmony Biosciences Holdings, Inc. | 2.16B | -2.90% | 847,402 | 959.90M |
| 237 | NEO | NeoGenomics, Inc. | 2.16B | 3.83% | 1,326,955 | 766.30M |
| 238 | PRGO | Perrigo Company plc | 2.15B | 0.19% | 1,085,105 | 4.14B |
| 239 | AXGN | Axogen, Inc. | 2.14B | -1.62% | 1,139,942 | 251.17M |
| 240 | NVAX | Novavax, Inc. | 2.14B | 2.49% | 6,154,336 | 413.80M |
| 241 | PHVS | Pharvaris N.V. | 2.13B | -1.94% | 280,624 | - |
| 242 | MD | Pediatrix Medical Group, Inc. | 2.11B | -1.15% | 184,763 | 1.95B |
| 243 | ADUS | Addus HomeCare Corporation | 2.10B | -0.44% | 76,995 | 1.48B |
| 244 | PGNY | Progyny, Inc. | 2.09B | -2.60% | 740,987 | 1.31B |
| 245 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.09B | -2.15% | 1,488,186 | 940.61M |
| 246 | RXRX | Recursion Pharmaceuticals, Inc. | 2.07B | -3.74% | 15,404,324 | 54.86M |
| 247 | VCEL | Vericel Corporation | 2.06B | -0.98% | 232,192 | 306.30M |
| 248 | VRDN | Viridian Therapeutics, Inc. | 2.06B | -0.77% | 1,095,176 | 71.13M |
| 249 | IMNM | Immunome, Inc. | 2.03B | -6.84% | 1,260,185 | 4.02M |
| 250 | FTRE | Fortrea Holdings Inc. | 2.01B | 0.81% | 361,395 | 2.68B |
| 251 | ADRX | ADARx Pharmaceuticals, Inc. | 2.01B | -0.17% | 151,708 | 6.13M |
| 252 | INSP | Inspire Medical Systems, Inc. | 2.00B | -3.03% | 357,916 | 898.74M |
| 253 | TRLV | Trulieve Cannabis Corp. | 1.95B | -2.50% | 577,629 | 1.14B |
| 254 | WGS | GeneDx Holdings Corp. | 1.95B | 2.48% | 361,381 | 454.43M |
| 255 | ASTH | Astrana Health, Inc. | 1.93B | -1.69% | 137,483 | 3.84B |
| 256 | VERA | Vera Therapeutics, Inc. | 1.93B | -3.32% | 2,044,401 | - |
| 257 | SDGR | Schrödinger, Inc. | 1.92B | -1.12% | 728,081 | 259.04M |
| 258 | ALVO | Alvotech | 1.91B | -2.64% | 885,414 | 494.61M |
| 259 | SGRY | Surgery Partners, Inc. | 1.91B | 3.16% | 679,739 | 3.37B |
| 260 | LKFT | Lakefront Biotherapeutics NV | 1.90B | -0.78% | 126,574 | 1.13B |
| 261 | LMAT | LeMaitre Vascular, Inc. | 1.88B | -0.87% | 134,612 | 262.43M |
| 262 | URGN | UroGen Pharma Ltd. | 1.87B | -0.12% | 469,033 | 188.73M |
| 263 | PVLA | Palvella Therapeutics, Inc. | 1.86B | -3.70% | 132,202 | - |
| 264 | XERS | Xeris Biopharma Holdings, Inc. | 1.86B | -2.25% | 1,009,140 | 335.41M |
| 265 | MLYS | Mineralys Therapeutics, Inc. | 1.84B | -6.57% | 2,304,908 | - |
| 266 | VIR | Vir Biotechnology, Inc. | 1.82B | -4.60% | 919,918 | 303.23M |
| 267 | AGIO | Agios Pharmaceuticals, Inc. | 1.81B | -1.78% | 367,968 | 98.34M |
| 268 | MESO | Mesoblast Limited | 1.80B | -2.17% | 177,270 | 120.25M |
| 269 | ZYME | Zymeworks Inc. | 1.79B | -0.59% | 220,427 | 37.13M |
| 270 | TRVI | Trevi Therapeutics, Inc. | 1.78B | -3.48% | 877,073 | - |
| 271 | XNCR | Xencor, Inc. | 1.76B | -5.27% | 1,585,104 | 104.97M |
| 272 | SRPT | Sarepta Therapeutics, Inc. | 1.76B | -4.39% | 1,886,671 | 1.97B |
| 273 | SEPN | Septerna, Inc. | 1.76B | 0.11% | 344,625 | 98.88M |
| 274 | ESTA | Establishment Labs Holdings Inc. | 1.75B | -4.48% | 272,328 | 245.82M |
| 275 | BHVN | Biohaven Ltd. | 1.74B | -2.46% | 1,530,625 | - |
| 276 | MRVI | Maravai LifeSciences Holdings, Inc. | 1.73B | -5.74% | 2,343,610 | 208.78M |
| 277 | ALHC | Alignment Healthcare, Inc. | 1.71B | 1.98% | 3,598,618 | 4.58B |
| 278 | SNDA | Sonida Senior Living, Inc. | 1.71B | -0.08% | 217,766 | 481.07M |
| 279 | XRAY | DENTSPLY SIRONA Inc. | 1.70B | -0.23% | 2,345,223 | 3.64B |
| 280 | PSNL | Personalis, Inc. | 1.69B | 0.38% | 2,777,006 | 69.67M |
| 281 | NVCR | NovoCure Limited | 1.69B | -1.49% | 365,473 | 699.19M |
| 282 | NTLA | Intellia Therapeutics, Inc. | 1.69B | -4.41% | 3,289,223 | 59.51M |
| 283 | ATEC | Alphatec Holdings, Inc. | 1.68B | -3.07% | 1,404,760 | 815.05M |
| 284 | AZTA | Azenta, Inc. | 1.67B | 1.22% | 392,789 | 613.81M |
| 285 | OMCL | Omnicell, Inc. | 1.67B | -0.84% | 204,389 | 1.25B |
| 286 | NUVB | Nuvation Bio Inc. | 1.67B | -3.16% | 5,912,444 | 169.90M |
| 287 | ARDT | Ardent Health, Inc. | 1.66B | 2.17% | 373,610 | 6.41B |
| 288 | ZBIO | Zenas BioPharma, Inc. | 1.65B | -4.09% | 313,023 | 1.00M |
| 289 | ALMR | Alamar Biosciences, Inc. | 1.64B | -2.68% | 488,405 | 100.42M |
| 290 | OCUL | Ocular Therapeutix, Inc. | 1.61B | -2.98% | 2,121,639 | 52.06M |
| 291 | KMTS | Kestra Medical Technologies, Ltd. | 1.61B | 0.46% | 73,525 | 106.73M |
| 292 | GENB | Generate Biomedicines, Inc. | 1.60B | -9.83% | 586,611 | 26.48M |
| 293 | GPCR | Structure Therapeutics Inc. | 1.60B | -6.11% | 927,187 | - |
| 294 | BRVE | Braveheart Bio, Inc. | 1.59B | -4.57% | 122,827 | - |
| 295 | ABSI | Absci Corporation | 1.56B | -6.20% | 1,894,557 | 1.56M |
| 296 | CMPS | COMPASS Pathways plc | 1.55B | -2.78% | 1,403,933 | - |
| 297 | ETON | Eton Pharmaceuticals, Inc. | 1.54B | -2.57% | 294,739 | 105.60M |
| 298 | ANIP | ANI Pharmaceuticals, Inc. | 1.52B | -3.32% | 149,980 | 978.38M |
| 299 | INVA | Innoviva, Inc. | 1.52B | -2.19% | 371,348 | 440.00M |
| 300 | PAHC | Phibro Animal Health Corporation | 1.50B | -1.40% | 212,727 | 1.52B |
| 301 | MAZE | Maze Therapeutics, Inc. | 1.49B | -2.89% | 305,432 | 20.00M |
| 302 | KRSA | Korsana Biosciences, Inc. | 1.49B | -3.61% | 128,455 | - |
| 303 | QURE | uniQure N.V. | 1.48B | -2.24% | 1,673,010 | 18.67M |
| 304 | CERT | Certara, Inc. | 1.46B | 3.84% | 1,654,816 | 421.75M |
| 305 | RARE | Ultragenyx Pharmaceutical Inc. | 1.46B | -2.81% | 2,549,568 | 717.00M |
| 306 | PCRX | Pacira BioSciences, Inc. | 1.45B | -0.06% | 966,005 | 746.16M |
| 307 | STOK | Stoke Therapeutics, Inc. | 1.44B | -7.29% | 268,239 | 27.59M |
| 308 | IMCR | Immunocore Holdings plc | 1.44B | -3.99% | 621,816 | 430.78M |
| 309 | AGL | agilon health, inc. | 1.43B | -0.08% | 91,447 | 5.92B |
| 310 | HCSG | Healthcare Services Group, Inc. | 1.43B | 1.26% | 376,039 | 1.86B |
| 311 | COAG | Hemab Therapeutics Holdings, Inc. | 1.43B | 0.66% | 215,559 | - |
| 312 | AMN | AMN Healthcare Services, Inc. | 1.41B | 0.29% | 165,867 | 3.43B |
| 313 | PNTG | The Pennant Group, Inc. | 1.41B | -0.44% | 62,631 | 1.10B |
| 314 | KLRA | Kailera Therapeutics, Inc. | 1.41B | -4.24% | 722,241 | - |
| 315 | RAPP | Rapport Therapeutics, Inc. | 1.40B | -3.05% | 194,664 | 20.00M |
| 316 | NUTX | Nutex Health Inc. | 1.40B | -0.85% | 114,810 | 846.72M |
| 317 | OMER | Omeros Corporation | 1.39B | -2.29% | 608,078 | 38.42M |
| 318 | AAPG | Ascentage Pharma Group International | 1.37B | -0.07% | 6,746 | 94.61M |
| 319 | FRNM | Freenome, Inc. | 1.37B | -3.71% | 557,106 | 35.41M |
| 320 | ANAB | AnaptysBio, Inc. | 1.36B | -1.22% | 236,946 | 106.09M |
| 321 | CNMD | CONMED Corporation | 1.35B | -0.93% | 263,343 | 1.37B |
| 322 | GHRS | GH Research PLC | 1.30B | -5.09% | 272,683 | - |
| 323 | NKTR | Nektar Therapeutics | 1.30B | -4.42% | 649,301 | 54.59M |
| 324 | INBX | Inhibrx Biosciences, Inc. | 1.29B | -2.86% | 182,167 | 1.30M |
| 325 | TYRA | Tyra Biosciences, Inc. | 1.29B | -4.49% | 174,107 | - |
| 326 | USPH | U.S. Physical Therapy, Inc. | 1.28B | 0.16% | 62,471 | 804.27M |
| 327 | DRTS | Alpha Tau Medical Ltd. | 1.27B | -3.75% | 354,628 | - |
| 328 | SVRA | Savara Inc. | 1.23B | 0.31% | 2,835,874 | - |
| 329 | INNV | InnovAge Holding Corp. | 1.23B | -1.37% | 236,723 | 989.71M |
| 330 | SNDX | Syndax Pharmaceuticals, Inc. | 1.23B | -16.98% | 5,146,197 | 252.25M |
| 331 | KARD | Kardigan, Inc. | 1.22B | -8.71% | 283,500 | - |
| 332 | TSHA | Taysha Gene Therapies, Inc. | 1.20B | -10.87% | 4,029,987 | 5.49M |
| 333 | ORIC | ORIC Pharmaceuticals, Inc. | 1.20B | -2.29% | 647,779 | - |
| 334 | CRON | Cronos Group Inc. | 1.19B | -0.16% | 426,811 | 179.09M |
| 335 | GDRX | GoodRx Holdings, Inc. | 1.18B | -0.43% | 461,667 | 785.23M |
| 336 | AHG | Akso Health Group | 1.16B | -0.80% | 8,789 | 13.83M |
| 337 | DMRA | Damora Therapeutics, Inc. | 1.16B | -7.13% | 148,916 | - |
| 338 | BCAX | Bicara Therapeutics Inc. | 1.16B | 0.92% | 731,236 | - |
| 339 | REPL | Replimune Group, Inc. | 1.15B | -6.43% | 729,774 | - |
| 340 | IRMD | IRADIMED CORPORATION | 1.15B | 0.54% | 62,741 | 86.34M |
| 341 | BVS | Bioventus Inc. | 1.15B | 0.81% | 163,629 | 581.85M |
| 342 | TNDM | Tandem Diabetes Care, Inc. | 1.15B | 0.09% | 764,275 | 1.04B |
| 343 | VOR | Vor Biopharma Inc. | 1.14B | -3.08% | 632,116 | - |
| 344 | OMDA | Omada Health, Inc. | 1.13B | -15.57% | 1,652,173 | 309.76M |
| 345 | AMPH | Amphastar Pharmaceuticals, Inc. | 1.13B | -0.73% | 150,983 | 730.02M |
| 346 | TRAX | First Tracks Biotherapeutics, Inc. | 1.13B | -7.28% | 677,445 | - |
| 347 | LBRX | LB Pharmaceuticals Inc | 1.11B | -3.95% | 142,625 | - |
| 348 | NBTX | Nanobiotix S.A. | 1.11B | -6.84% | 155,743 | 13.15M |
| 349 | PRCT | PROCEPT BioRobotics Corporation | 1.10B | -1.74% | 829,301 | 337.34M |
| 350 | TDOC | Teladoc Health, Inc. | 1.10B | 2.20% | 2,930,390 | 2.49B |
| 351 | ENOV | Enovis Corporation | 1.10B | 4.05% | 564,466 | 2.30B |
| 352 | STAA | STAAR Surgical Company | 1.09B | -1.50% | 207,339 | 339.59M |
| 353 | IART | Integra LifeSciences Holdings Corporation | 1.09B | -0.14% | 435,627 | 1.65B |
| 354 | HROW | Harrow, Inc. | 1.06B | -2.78% | 555,252 | 275.59M |
| 355 | AORT | Artivion, Inc. | 1.06B | -0.37% | 412,210 | 471.47M |
| 356 | LTGO | Latigo Biotherapeutics, Inc. | 1.06B | -0.56% | 162,483 | - |
| 357 | JANX | Janux Therapeutics, Inc. | 1.05B | -5.34% | 446,396 | 24.00M |
| 358 | AVLN | Avalyn Pharma Inc. | 1.04B | -5.50% | 244,028 | - |
| 359 | HSTM | HealthStream, Inc. | 1.04B | 1.23% | 91,886 | 321.12M |
| 360 | LMRI | Lumexa Imaging Holdings, Inc. | 1.02B | -0.70% | 207,964 | 1.04B |
| 361 | CSTL | Castle Biosciences, Inc. | 1.01B | 1.10% | 120,036 | 357.28M |
| 362 | CBLL | CeriBell, Inc. | 1.00B | 3.35% | 351,271 | 101.96M |
| 363 | OPK | OPKO Health, Inc. | 1.00B | -2.90% | 1,002,435 | 587.90M |
| 364 | MNKD | MannKind Corporation | 982.31M | -2.40% | 2,594,017 | 393.63M |
| 365 | MGTX | MeiraGTx Holdings plc | 963.31M | -3.37% | 490,120 | 397.50M |
| 366 | QDEL | QuidelOrtho Corporation | 961.43M | 5.81% | 2,013,572 | 2.67B |
| 367 | BBNX | Beta Bionics, Inc. | 950.71M | 1.12% | 267,344 | 119.01M |
| 368 | IMTX | Immatics N.V. | 950.00M | -3.61% | 603,572 | 47.65M |
| 369 | AKTS | Aktis Oncology, Inc. | 938.86M | -2.65% | 193,882 | 10.06M |
| 370 | CGEM | Cullinan Therapeutics, Inc. | 912.55M | -5.15% | 304,099 | - |
| 371 | MLTX | MoonLake Immunotherapeutics | 901.28M | -0.84% | 1,445,148 | - |
| 372 | SIBN | SI-BONE, Inc. | 895.92M | -0.55% | 169,588 | 213.60M |
| 373 | KURA | Kura Oncology, Inc. | 886.05M | -4.18% | 1,786,907 | 77.23M |
| 374 | RIGL | Rigel Pharmaceuticals, Inc. | 884.87M | -2.95% | 63,160 | 276.79M |
| 375 | ANRO | Alto Neuroscience, Inc. | 880.99M | -7.04% | 394,121 | - |
| 376 | JBIO | Jade Biosciences, Inc. | 868.74M | -2.43% | 846,603 | - |
| 377 | SPTX | Seaport Therapeutics, Inc. | 868.27M | -5.42% | 127,406 | - |
| 378 | SLBT | SL Science Holding Limited | 866.80M | 0.66% | 90,761 | 3.27M |
| 379 | GLUE | Monte Rosa Therapeutics, Inc. | 864.65M | -3.66% | 1,434,882 | 28.73M |
| 380 | ALMS | Alumis Inc. | 858.16M | -6.09% | 1,092,162 | 7.40M |
| 381 | AHCO | AdaptHealth Corp. | 845.81M | 3.26% | 1,160,991 | 3.36B |
| 382 | ODTX | Odyssey Therapeutics, Inc. | 830.19M | -5.12% | 82,294 | 99.00K |
| 383 | GMRS | GMR Solutions Inc. | 828.51M | 0.57% | 557,378 | 5.88B |
| 384 | INMD | InMode Ltd. | 825.71M | 0.45% | 259,535 | 374.63M |
| 385 | SGP | SpyGlass Pharma, Inc. | 814.79M | -2.01% | 44,070 | - |
| 386 | ABUS | Arbutus Biopharma Corporation | 811.18M | -1.20% | 2,002,572 | 181.72M |
| 387 | AVBP | ArriVent BioPharma, Inc. | 799.52M | -1.49% | 1,243,917 | - |
| 388 | DNA | Ginkgo Bioworks Holdings, Inc. | 797.31M | 0.42% | 1,221,305 | 132.42M |
| 389 | CRVS | Corvus Pharmaceuticals, Inc. | 793.26M | -6.17% | 1,103,402 | - |
| 390 | VREX | Varex Imaging Corporation | 778.89M | - | 78,990 | 865.00M |
| 391 | ARDX | Ardelyx, Inc. | 774.97M | -3.72% | 4,027,066 | 450.89M |
| 392 | GERN | Geron Corporation | 770.97M | -1.64% | 4,303,712 | 204.56M |
| 393 | HELP | Helus Pharma Inc. | 753.98M | -6.44% | 2,929,543 | - |
| 394 | ANL | Adlai Nortye Group Ltd. | 750.88M | -18.00% | 820,635 | 18.06M |
| 395 | OBX | Obsidian Therapeutics, Inc. | 742.51M | -6.02% | 239,624 | - |
| 396 | APMD | Apnimed, Inc. | 738.95M | -4.72% | 109,698 | 115.12M |
| 397 | LXRX | Lexicon Pharmaceuticals, Inc. | 727.50M | -0.91% | 1,405,290 | 41.47M |
| 398 | ANNX | Annexon, Inc. | 726.09M | -3.28% | 2,076,263 | - |
| 399 | IMMX | Immix Biopharma, Inc. | 724.57M | -5.51% | 989,154 | - |
| 400 | ACHV | Achieve Life Sciences, Inc. | 721.35M | -0.71% | 793,874 | - |
| 401 | SANA | Sana Biotechnology, Inc. | 718.47M | -8.40% | 3,702,619 | - |
| 402 | GYRE | Gyre Therapeutics, Inc. | 716.79M | -1.53% | 49,399 | 109.82M |
| 403 | CADL | Candel Therapeutics, Inc. | 713.15M | -4.70% | 753,229 | - |
| 404 | COLL | Collegium Pharmaceutical, Inc. | 705.15M | -1.77% | 340,837 | 808.21M |
| 405 | CTKB | Cytek Biosciences, Inc. | 702.56M | 1.79% | 879,013 | 206.71M |
| 406 | STLN | Starling Oncology, Inc. | 694.05M | -1.59% | 834,484 | 587.24M |
| 407 | FDMT | 4D Molecular Therapeutics, Inc. | 690.00M | -3.92% | 570,431 | 92.01M |
| 408 | MDXG | MiMedx Group, Inc. | 686.53M | -2.48% | 414,749 | 355.17M |
| 409 | OABI | OmniAb, Inc. | 686.24M | -1.05% | 429,244 | 38.46M |
| 410 | VSTM | Verastem, Inc. | 681.04M | -8.85% | 2,080,969 | 87.53M |
| 411 | PHR | Phreesia, Inc. | 673.47M | 0.28% | 297,151 | 507.79M |
| 412 | ATTO | Attovia Therapeutics, Inc. | 667.88M | 0.27% | 201,212 | 1.80M |
| 413 | PHAR | Pharming Group N.V. | 663.24M | -0.94% | 18,424 | 366.48M |
| 414 | IVA | Inventiva S.A. | 657.01M | -6.09% | 1,359,862 | 2.81M |
| 415 | AURA | Aura Biosciences, Inc. | 654.38M | -3.52% | 1,009,401 | - |
| 416 | AVTX | Avalo Therapeutics, Inc. | 653.21M | -8.01% | 1,143,627 | 59.00K |
| 417 | PACB | Pacific Biosciences of California, Inc. | 648.08M | -0.71% | 8,119,122 | 159.27M |
| 418 | AVR | Anteris Technologies Global Corp. | 631.76M | -2.56% | 359,684 | 2.24M |
| 419 | SLDB | Solid Biosciences Inc. | 629.41M | -12.52% | 2,059,834 | - |
| 420 | OLMA | Olema Pharmaceuticals, Inc. | 620.36M | -3.67% | 797,165 | - |
| 421 | ZVRA | Zevra Therapeutics, Inc. | 619.37M | -7.86% | 622,901 | 136.07M |
| 422 | SOPH | SOPHiA GENETICS SA | 611.64M | -0.48% | 153,750 | 86.17M |
| 423 | DSGN | Design Therapeutics, Inc. | 610.17M | -10.63% | 481,704 | - |
| 424 | WVE | Wave Life Sciences, Inc. | 607.89M | -5.95% | 2,114,780 | 65.37M |
| 425 | PRME | Prime Medicine, Inc. | 603.10M | -6.09% | 2,889,322 | 4.07M |
| 426 | NVCT | Nuvectis Pharma, Inc. | 599.99M | -6.48% | 132,703 | - |
| 427 | IRWD | Ironwood Pharmaceuticals, Inc. | 591.56M | -4.79% | 1,463,884 | 389.32M |
| 428 | WEAV | Weave Communications, Inc. | 590.79M | 0.07% | 3,301,644 | 257.79M |
| 429 | AQST | Aquestive Therapeutics, Inc. | 589.90M | -2.29% | 880,006 | 54.09M |
| 430 | CLYM | Climb Bio, Inc. | 589.87M | -5.17% | 424,385 | - |
| 431 | FLGT | Fulgent Genetics, Inc. | 586.49M | -0.72% | 115,083 | 323.93M |
| 432 | CRMD | CorMedix Inc. | 579.13M | -0.40% | 714,454 | 462.25M |
| 433 | KIDS | OrthoPediatrics Corp. | 578.72M | 0.38% | 102,289 | 252.72M |
| 434 | CBIO | Crescent Biopharma, Inc. | 569.25M | -8.02% | 79,820 | 11.88M |
| 435 | SGMT | Sagimet Biosciences Inc. | 568.69M | -8.86% | 1,941,410 | - |
| 436 | PHAT | Phathom Pharmaceuticals, Inc. | 563.16M | -0.56% | 852,117 | 239.66M |
| 437 | STTK | Shattuck Labs, Inc. | 563.04M | -7.88% | 1,187,824 | 1.00M |
| 438 | ETRA | Electra Therapeutics, Inc. | 563.02M | -3.76% | 358,172 | - |
| 439 | FTH | Faeth Therapeutics, Inc. | 559.45M | -6.88% | 242,368 | - |
| 440 | SLN | Silence Therapeutics plc | 537.67M | -7.46% | 945,156 | 615.00K |
| 441 | DCTH | Delcath Systems, Inc. | 536.44M | -1.34% | 154,868 | 95.42M |
| 442 | PBYI | Puma Biotechnology, Inc. | 529.11M | -0.39% | 159,030 | 231.24M |
| 443 | EVH | Evolent Health, Inc. | 527.99M | 9.88% | 1,617,671 | 2.10B |
| 444 | DRUG | Bright Minds Biosciences Inc. | 519.44M | -2.55% | 173,158 | - |
| 445 | CTMX | CytomX Therapeutics, Inc. | 518.60M | -1.65% | 3,821,298 | 18.30M |
| 446 | BWAY | BrainsWay Ltd. | 511.89M | 5.06% | 116,781 | 60.70M |
| 447 | DBVT | DBV Technologies S.A. | 511.43M | -5.34% | 240,178 | 5.04M |
| 448 | ACRS | Aclaris Therapeutics, Inc. | 510.78M | -3.61% | 1,714,890 | 8.22M |
| 449 | VALN | Valneva SE | 508.53M | -5.40% | 13,952 | 163.30M |
| 450 | TCMD | Tactile Systems Technology, Inc. | 504.69M | -1.50% | 86,424 | 350.31M |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 4.81M |
| 452 | MNPR | Monopar Therapeutics Inc. | 503.48M | -2.65% | 136,760 | - |
| 453 | BLSM | BlossomHill Therapeutics, Inc. | 503.16M | -8.34% | 61,730 | - |
| 454 | MASS | 908 Devices Inc. | 498.07M | 1.95% | 105,340 | 60.84M |
| 455 | SSII | SS Innovations International, Inc. | 496.96M | -2.75% | 52,882 | 52.40M |
| 456 | EOLS | Evolus, Inc. | 495.38M | -3.23% | 390,473 | 316.49M |
| 457 | RZLT | Rezolute, Inc. | 490.92M | -3.90% | 655,146 | - |
| 458 | RGNX | REGENXBIO Inc. | 481.90M | -6.05% | 897,974 | 174.48M |
| 459 | ALT | Altimmune, Inc. | 481.43M | -3.32% | 2,643,788 | 31.00K |
| 460 | TLRY | Tilray Brands, Inc. | 481.05M | -2.38% | 3,319,347 | 963.10M |
| 461 | SENS | Senseonics Holdings, Inc. | 479.57M | -1.84% | 362,949 | 48.55M |
| 462 | EVO | Evotec SE | 479.54M | -1.82% | 99,826 | 819.47M |
| 463 | PROK | ProKidney Corp. | 474.65M | -5.99% | 1,376,032 | 818.00K |
| 464 | OCS | Oculis Holding AG | 471.63M | -3.05% | 146,852 | 1.45M |
| 465 | SGHT | Sight Sciences, Inc. | 464.94M | -5.86% | 283,749 | 83.38M |
| 466 | CERS | Cerus Corporation | 461.49M | 1.33% | 1,022,620 | 221.55M |
| 467 | EPRX | Eupraxia Pharmaceuticals Inc. | 458.14M | -6.69% | 676,251 | - |
| 468 | TKNO | Alpha Teknova, Inc. | 456.62M | -2.24% | 131,822 | 43.70M |
| 469 | ALLO | Allogene Therapeutics, Inc. | 454.32M | -6.07% | 4,361,190 | 4.64M |
| 470 | ANGO | AngioDynamics, Inc. | 453.35M | -5.44% | 860,957 | 325.38M |
| 471 | ARVN | Arvinas, Inc. | 452.47M | -7.11% | 514,386 | 316.70M |
| 472 | NRC | NRC Health | 444.82M | -1.47% | 28,226 | 140.00M |
| 473 | MPLT | MapLight Therapeutics, Inc. | 442.94M | -7.33% | 141,578 | - |
| 474 | NPCE | NeuroPace, Inc. | 442.44M | -0.85% | 32,232 | 106.99M |
| 475 | NGNE | Neurogene Inc. | 442.05M | -9.62% | 188,876 | 925.00K |
| 476 | KMDA | Kamada Ltd. | 438.41M | -1.98% | 67,840 | 191.85M |
| 477 | PRTA | Prothena Corporation plc | 434.82M | 0.47% | 362,105 | 54.53M |
| 478 | AGMB | AgomAb Therapeutics NV | 433.63M | -3.14% | 49,815 | - |
| 479 | YDES | YD Bio Limited | 432.07M | -3.63% | 19,089 | 1.24M |
| 480 | ENTX | Entera Bio Ltd. | 431.33M | -6.42% | 483,355 | 42.00K |
| 481 | OVID | Ovid Therapeutics Inc. | 430.63M | -8.51% | 1,012,607 | 1.58M |
| 482 | AUTL | Autolus Therapeutics plc | 427.19M | -7.76% | 1,842,001 | 117.39M |
| 483 | DMAC | DiaMedica Therapeutics Inc. | 420.35M | -4.94% | 143,078 | - |
| 484 | ASMB | Assembly Biosciences, Inc. | 420.24M | -9.35% | 146,241 | 74.85M |
| 485 | ZURA | Zura Bio Limited | 416.38M | 8.62% | 20,967,818 | - |
| 486 | RCEL | AVITA Medical, Inc. | 413.80M | 0.07% | 211,378 | 75.63M |
| 487 | TECX | Tectonic Therapeutic, Inc. | 412.98M | -5.48% | 78,156 | - |
| 488 | CAPR | Capricor Therapeutics, Inc. | 410.46M | -5.49% | 1,691,829 | 11.13M |
| 489 | CTEV | Claritev Corporation | 407.25M | -1.23% | 61,898 | 994.67M |
| 490 | SPRY | ARS Pharmaceuticals, Inc. | 406.24M | -2.27% | 1,106,030 | 116.93M |
| 491 | CYH | Community Health Systems, Inc. | 405.90M | 2.57% | 1,415,776 | 11.98B |
| 492 | AVIR | Atea Pharmaceuticals, Inc. | 401.02M | -0.60% | 99,953 | - |
| 493 | MYGN | Myriad Genetics, Inc. | 399.82M | -0.48% | 627,819 | 806.60M |
| 494 | CARL | Carlsmed, Inc. | 399.44M | -1.01% | 24,119 | 63.30M |
| 495 | SRTA | Strata Critical Medical, Inc. | 398.10M | -0.88% | 358,269 | 255.98M |
| 496 | AUNA | Auna S.A. | 395.23M | 3.09% | 358,137 | 1.37B |
| 497 | EDIT | Editas Medicine, Inc. | 382.41M | -9.45% | 1,799,795 | 47.01M |
| 498 | SI | Shoulder Innovations, Inc. | 380.78M | 0.33% | 37,816 | 60.06M |
| 499 | OFIX | Orthofix Medical Inc. | 373.11M | -1.29% | 162,642 | 833.19M |
| 500 | GALT | Galectin Therapeutics Inc. | 372.14M | -4.65% | 125,348 | - |